Navamedic ASA (OSL:NAVA)

Norway · Delayed Price · Currency is NOK

19.80

0.00 (0.00%)

Apr 1, 2026, 12:24 PM CET

Revenue by Segment

Financials in millions NOK. Fiscal year is January - December.

Millions NOK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Pharma and Healthcare Division			512.00M	382.14M	278.44M	209.88M	188.76M
Pharma and Healthcare Division Growth			33.98%	37.24%	32.67%	11.19%	2.64%
Total			512.00M	382.14M	278.44M	209.88M	188.76M
Total Growth			33.98%	37.24%	32.67%	11.19%	2.64%

Revenue by Geography

Financials in millions NOK. Fiscal year is January - December.

Millions NOK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Norway			214.12M	198.89M	138.05M	64.32M	51.55M
Norway Growth			7.66%	44.07%	114.62%	24.77%	20.73%
Sweden			158.92M	96.74M	59.88M	54.18M	54.89M
Sweden Growth			64.27%	61.57%	10.52%	-1.30%	-8.36%
Denmark			38.07M	28.15M	27.61M	33.89M	30.80M
Denmark Growth			35.25%	1.94%	-18.53%	10.03%	-4.94%
Finland			27.71M	17.95M	13.85M	16.34M	15.36M
Finland Growth			54.35%	29.64%	-15.28%	6.40%	12.95%
The Netherlands			54.01M	26.37M	-	-	-
The Netherlands Growth			104.85%	-	-	-	-
Other countries			19.18M	14.05M	39.06M	41.14M	36.15M
Other countries Growth			36.53%	-64.03%	-5.07%	13.82%	2.40%
Total			512.00M	382.14M	278.44M	209.88M	188.76M
Total Growth			33.98%	37.24%	32.67%	11.19%	2.64%

Source: S&P Global Market Intelligence.